* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download BIOLOGICAL HAZARDS IN LAB & NSI
Microbicides for sexually transmitted diseases wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Hepatitis B wikipedia , lookup
Traveler's diarrhea wikipedia , lookup
Hepatitis C wikipedia , lookup
History of biological warfare wikipedia , lookup
Biological warfare wikipedia , lookup
EOH 3202 BIOLOGICAL HAZARD & BIOSAFETY LEVEL ANITA BINTI ABD. RAHMAN M.D. ; M.Comm. H [OH]; AOEMM DEPARTMENT of COMMUNITY HEALTH 7th November 2012 CONTENT ► BIOLOGICAL HAZARD Definition Types & Exposure Example - epidemiology Prevention & Control ►BIOSAFETY LEVEL OCCUPATIONAL HAZARDS PSYCHOLOGICAL Stress, boredom PHYSICAL AGENTS noise, vibration, radiation, defective illumination, temperature extremes BIOLOGICAL AGENTS viruses, bacteria, fungi, parasites, insects, etc. CHEMICAL AGENTS dusts, gases, vapors, fumes, mists, etc. LACK OF ERGONOMIC PRINCIPLES exhaustive physical exertions, excessive standing, improper motions, lifting heavy load, job monotony, etc. DEFINITION ► BIOLOGICAL HAZARD @ BIOHAZARDS A substance derived from an organism, that poses a threat to (primarily) human health. ►A naturally occurring substance. Example: ► medical waste, samples of a microorganism, virus or toxin (from a biological source) ► substances harmful to animals- zoonotic diseases CONCERN? Potential for acquiring a laboratory-acquired infections (LAIs) Contamination of the environment Contamination of research TYPES ► Divided into: ►Body fluids pathogen Protozoa, Parasites ►Animal – – Bacteria, Viruses, Fungi, insects, birds ►Recombinant DNA ►Nano-technology – genetic engineering, cloning EXPOSURE EXPOSURE ► Direct contact Broken skin – NSI Allergy/Irritant ► Inhalation ► Ingestion EXPOSURE Routes of Transmission Infection Source •Specimens •Culture & stocks •Research animals •Item contaminated with above Susceptible Host • Age • Immune system • Vaccination status • pre-morbid condition: • DM WHO IS AT RISK? ► Laboratory staff ► Health Care Workers Doctor, Nurses, Medical Assistant ► Agricultural workers ► Armed Forces EXAMPLE ► Occupational Exposure to blood borne pathogen 2 million exposure per year Among HCW: ►40% of Hepatitis B ►40% of Hepatitis C ►4% of HIV Needle Stick Injury WHO Environmental Burden of Disease No .3 PREVALENCE Source : OHU, MOH Bilangan dan kadar kecederaan di kalangan anggota KKM 1998-2005 Bilangan kecederaan 1000 75 56 800 37 80 67 64 972 70 53 830 799 600 842 726 571 400 200 90 85 13 60 50 40 30 377 20 10 125 0 0 1998 1999 2000 2001 2002 2003 2004 2005 Tahun Number of Injuries Injury Rate Per 10,000 Worker Kadar Kecederaan setiap 10,000 Pekerja 1200 PREVALENCE Source : OHU, MOH EXAMPLE ► MALAYSIA HEPATITIS B 1999 - 5295 cases reported & 9% were carriers TB 2005 – 11 notification of HCW with MTB LAB-ACQUIRED INFECTIONS (LAI’s) WHO WHAT WHERE WHEN HOW Doctor, Nurse Researcher SARS Singapore Taiwan December 2003 Contact Microbiologist West Nile Virus US August 2002 Laceration Laboratory Worker Meningococcal Disease US 2000 Aerosol? Laboratory worker Vaccinia virus Europe 2002 Contact OH- HIERARCHY OF CONTROL ► Elimination/Substitution ► Engineering control Biosafety Cabinet (BSL) ► Administrative control Work Practice - SOP Standard Precaution ► PPE Gloves, mask, gown PREVENTION & CONTROL ► WHO has long recognized that safety and in particular, biological safety are important international issues. ► In 1983 - 1st edition of its Laboratory Biosafety Manual which encourages countries to prepare : Specific Codes of Practice for the safe handling of pathogenic microorganisms in laboratories within their geographical borders & provide expert guidance for developing such codes of practice. CONVENTION ON BIOLOGICAL DIVERSITY ► At the 1992 Earth Summit in Rio de Janeiro, world leaders agreed on a comprehensive strategy for : "sustainable development“- ► One of the key agreements adopted at Rio was the Convention on Biological Diversity. ► The Convention establishes three main goals: 1. the conservation of biological diversity 2. the sustainable use of its components, and 3. the fair and equitable sharing of the benefits from the use of genetic resources. CONVENTION ON BIOLOGICAL DIVERSITY ► Revision : In accordance with the precautionary approach contained in Principle 15 of the Rio Declaration on Environment and Development Ensuring an adequate level of protection in the field of the safe transfer, handling and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, and specifically focusing on transboundary movements. CARTAGENA PROTOCOL ON BIOSAFETY ► The Conference of the Parties to the Convention on Biological Diversity adopted a supplementary agreement to the Convention known as the Cartagena Protocol on Biosafety on 29 January 2000. ► The Protocol seeks to protect biological diversity from the potential risks posed by living modified organisms (LMO) resulting from modern biotechnology. PRINCIPLE OF BIOSAFETY ► Containment Safe management of infectious agent in a laboratory ► Purpose Reduce/eliminate exposure to workers, persons & environment PRINCIPLE OF BIOSAFETY ► PRIMARY CONTAINMENT Protection of workers & environment from exposure to hazard ► Good microbiological technique ► Appropriate safety equipment ► Vaccination ► SECONDARY CONTAINMENT Combination of facility design & operational practices; 3 elements: ► Lab practices & technique ► Safety equipment ► Facility design BIOSAFETY LEVEL (BSL) Combination of agent involved, lab practices & techniques, safety equipment & facilities. Microorganisms are categorized in risk groups (relative risk) based on the following factors: Pathogenicity of the organism Mode of transmission and host range Availability of effective preventive measures (e.g. vaccines) Availability of effective treatment (e.g. antibiotics) Other factors BIOSAFETY LEVEL (BSL) ► LABORATORY BIOSAFETY MANUAL 2ND EDITION (REVISED) WHO, Geneva 2003 References are made to the relative hazards of infective microorganisms by WHO Risk Groups 1, 2, 3 & 4. This risk group classification is to be used for laboratory work only. The risk assessment of the work to be done with a specific agent will determine the appropriate combination of these elements. CLASSIFICATION OF INFECTIVE MICROORGANISMS BY RISK GROUP ► RISK GROUP 1 (low individual and community risk) This group includes those microorganisms which are unlikely to cause disease in healthy workers or animals (pose little or no risk) – Lactobacillus sp, Bacillus subtilis ► RISK GROUP 2 (moderate individual risk, low community risk) Can cause human disease, but under normal circumstances is unlikely to be a serious hazard to laboratory workers, the community, livestock or the environment . Effective treatment and preventive measures are available and the risk of spread is limited. E. Coli 0157, Measles, Mumps, Hepatitis B, HIV CLASSIFICATION OF INFECTIVE MICROORGANISMS BY RISK GROUP ► RISK GROUP 3 (high individual risk, low community risk) A pathogen that usually causes serious human or animal disease, or which can result in serious economic consequences but does not ordinarily spread by casual contact from one individual to another, or that can be treated by antimicrobial or antiparasitic agents. Mycobaterium TB, Anthrax, Small Pox, ► RISK GROUP 4 (high individual risk, high community risk) A pathogen that usually produces very serious human animal disease, often untreatable, and may be readily transmitted from one individual to another, or from animal to human or vice-versa directly or indirectly, or casual contact – H5N1, Ebola virus BIOSAFETY LEVEL (BSL) Laboratories are designated according to their design features, construction and containment facilities as : Basic Basic Containment Maximum containment ► - Biosafety Level 1 - Biosafety Level 2 - Biosafety Level 3 - Biosafety Level 4. NIH & CDC : 4 biosafety levels (BSLs) are described which comprise all of the elements of containment. Each combination is specifically appropriate for : the operations performed the documented or suspected routes of transmission of the infectious agents for the laboratory function or activity. BIOSAFETY LEVEL (BSL) _ As the level so does ; BSL 4 the risk of the organism to humans, animals, plants and/or the environment BSL 3 the procedural and facility requirements BSL 2 BSL 1 _ the level of containment required the degree of protection for personnel, the environment and the community. Summary of Recommended Biosafety Level for Infectious Agent C. Recommended Guidelines REMEMBER… ► Every incident (no matter how small) must be investigated to determine if the risk of exposure exists, and what could be done to prevent the possibility of reoccurrence. THANK YOU